id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-353375-92pu0pp0	Hung, Jennifer C. H.	Implications of COVID-19 for uveitis patients: perspectives from Hong Kong	2020-04-29		.txt	text/plain	1008	57	41	Uveitis patients are potentially at higher risk of exposure to infections including COVID-19, as they may require systemic immunosuppression to control ocular inflammation, including corticosteroids and other disease-modifying agents such as antimetabolites, calcineurin Inhibitors, alkylating agents, or biologics. Patients with active non-infective uveitis not responding to topical treatment alone may require periocular steroids or systemic immunosuppression to manage their inflammation. Patients due to start systemic therapy should be considered for screening for SARS-CoV-2 in addition to the usual panel of infection diseases, especially if they display symptoms of COVID-19 or are in close contacts with proven cases. These patients may require topical or periocular treatment in the meantime, depending on their overall clinical condition and uveitis activity. If the healthcare system becomes overwhelmed by COVID-19 cases, ophthalmologists may have to be diverted to care for medical patients, as has happened to our colleagues in Italy, to the detriment of patients with active eye disease.	./cache/cord-353375-92pu0pp0.txt	./txt/cord-353375-92pu0pp0.txt